With the focus shifting from containment to treatment of COVID-19, the Prime Minister conducted a detailed review of the current status of India's efforts in vaccine development, drug discovery, diagnosis and testing.

For our comprehensive coverage and latest updates on COVID-19 click here.

The government expressed confidence in the competence of Indian vaccine companies, their manufacturing capacity and global presence while stating in statement that "over 30 Indian vaccines are in different stages of development, with a few entering the trial stages." Similarly, in drug development, three approaches are being taken.

First, the repurposing of the existing drugs and at least four drugs are undergoing synthesis and examination in this category. Secondly, the development of new candidate drugs and molecules are being driven by linking high performance computational approaches with laboratory verification. Thirdly, plant extracts and products are being examined for general anti-viral properties.

In diagnosis and testing, several academic research institutions and startups have developed new tests, both for the RT-PCR approach and for antibody detection, said the government. In addition, by linking laboratories all over the country, capacity for both these kinds of tests has been enormously scaled up, the statement added. Meanwhile, the problem of importing reagents for testing has been addressed by consortia of Indian startups and firms, meeting the current requirements. The government insisted that the current thrust also holds promise for the development of a robust long-term industry in this area.

The Prime Minister noted that the "extraordinary coming together" of academia, industry and government in a combined manner with speedy but efficient regulatory process in this hour of crisis when all entities need to work together. He is believed to have told during the meeting that such coordination and speed should be embedded into a standard operating procedure.

Appreciating the scientific coming together of computer science, chemistry and biotechnology in drug discovery, the Prime Minister suggested that a hackathon be held on this subject, linking computer science to synthesis and testing in the laboratory. The Prime Minister said that the successful candidates from the hackathon could be picked by the startups for further development and scaling up of their efforts. "This kind of pride, originality and sense of purpose should dominate our approach going ahead," the Prime Minister is believed to have told those present in the meeting.

This stock taking and secretion for a homegrown vaccine for COVID-19 come closely on the heels of the Prime Minister stressing on "self sustenance" as the way forward in many of his addresses off late.